{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicjapx5abfb4et54zjikv7y7ugye2j7p4ikp3domnjdupr3nx634y",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mkpqjoutnph2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/04/30/supreme-court-hearing-skinny-labels-astrazeneca-uk-expansion/?utm_campaign=rss",
  "publishedAt": "2026-04-30T13:17:31.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "AstraZeneca will resume expansion of its U.K. R&D operations after the trade deal with the U.S. included measures to lift U.K. drug spending",
  "title": "STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and more",
  "updatedAt": "2026-04-30T13:17:36.000Z"
}